Posts Archive for April 2014

FDA approved the use of a new prefilled syringe Norditropin

Apr.01, 2014

FDA approved the use of a new prefilled syringe Norditropin FlexPro

The U.S. Food and Drug Administration (FDA) approved the use of a new  prefilled syringe Norditropin FlexPro made by a pharmaceutical company Novo Nordisk AS. The syringe is designed for the introduction of growth hormone Norditropin (somatropin) in children and adults.

The disposable prefilled syringe Norditropin FlexPro is equipped with a new metering mechanism, and its modern design facilitates the training and use by patients. In addition, it is equipped with a sound indicator of dosing. The use of this prefilled syringe requires to use cartridges. Norditropin FlexPro is available in 3 different doses: 5 mg / 1,5 ml, 10 mg / 1,5 ml and 15 mg / 1,5 ml.

Generic Xenical

Apr.01, 2014

What is Xenical (orlistat)?

Generic Xenical is a powerful and specific inhibitor of gastrointestinal lipases. Orlistat reduces the amount of calories entering the organism. This helps to reduce excessive weight loss. Generic Xenical is indicated for the treatment of obesity and overweight in combination with healthy diet and moderate physical exercises.

Xenical (orlistat) is a powerful and specific inhibitor of gastrointestinal lipases. Therapeutic effect of Orlistat oral is manifested in the stomach and small intestine. The action mechanism of Xenical is related to formation of covalent bond with the active serine site of gastric and pancreatic lipases. Inactivated enzyme loses the ability to break down lipids coming in the form of triglycerides, fatty acids and monoglycerides. As a result the medication decreases the number of calories entering the organism (unsplit triglycerides are not absorbed in the blood circulation). This helps to decrease body weight.
Xenical oral exerts its therapeutic action without absorption into the systemic circulation.
Xenical increases the concentration of fat in the stool in 24-48 hours after administration.